NK/T cell non-Hodgkin lymphoma in a HIV-positive patient

Por Panarelli, Nicole C., Furman, Richard R., Wang, Y. Lynn, Elstrom, Rebecca, Cohen, Jules A., Chadburn, Amy
Publicado em 2010

Extracorporeal Membrane Oxygenation as a Bridge to Chemotherapy in an Orthodox Jewish Patient

Por Meltzer, Ellen C., Ivascu, Natalia S., Acres, Cathleen A., Stark, Meredith, Furman, Richard R., Fins, Joseph J.
Publicado em 2014

Overlap Between Systemic Lupus Erythematosus and Kikuchi Fujimoto Disease: A Clinical Pathology Conference held by the Department of Rheumatology at Hospital for Special Surgery

Por Gordon, Jessica K., Magro, Cynthia, Lu, Theresa, Schneider, Robert, Chiu, April, Furman, Richard R., Solomon, Garron, Bass, Anne, Erkan, Doruk
Publicado em 2009

Therapy of B-cell malignancies by anti–HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways

Por Stein, Rhona, Gupta, Pankaj, Chen, Xiaochuan, Cardillo, Thomas M., Furman, Richard R., Chen, Susan, Chang, Chien-Hsing, Goldenberg, David M.
Publicado em 2010

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

Por Islam Naziba, Broekman M Johan, Olson Kim E, Pulte Dianne, Ballard Harold S, Furman Richard R, Olson Ashley E, Marcus Aaron J
Publicado em 2007-05-01

CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia

Por Pulte, Dianne, Olson, Kim E, Broekman, M Johan, Islam, Naziba, Ballard, Harold S, Furman, Richard R, Olson, Ashley E, Marcus, Aaron J
Publicado em 2007

Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas

Por Martin, Peter, Furman, Richard R., Rutherford, Sarah, Ruan, Jia, Ely, Scott, Greenberg, June, Coleman, Morton, Goldsmith, Stanley J., Leonard, John P.
Publicado no Leuk Lymphoma (2015)

Durable Responses with the Metronomic Regimen RT-PEPC in Elderly Patients with Recurrent Mantle Cell Lymphoma

Por Ruan, Jia, Martin, Peter, Coleman, Morton, Furman, Richard R., Cheung, Ken, Faye, Adam, Elstrom, Rebecca, Lachs, Mark, Hajjar, Katherine A., Leonard, John P.
Publicado em 2010

CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia

Por Pulte, Dianne, Furman, Richard R., Broekman, M. Johan, Drosopoulos, Joan H. F., Ballard, Harold S., Olson, Kim E., Kizer, Jorge R., Marcus, Aaron J.
Publicado em 2011

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma

Por Ruan, Jia, Martin, Peter, Shah, Bijal, Schuster, Stephen J., Smith, Sonali M., Furman, Richard R., Christos, Paul, Rodriguez, Amelyn, Svoboda, Jakub, Lewis, Jessica, Katz, Orel, Coleman, Morton, Leonard, John P.
Publicado no N Engl J Med (2015)

Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL and CD40L

Por Cols, Montserrat, Barra, Carolina M., He, Bing, Puga, Irene, Xu, Weifeng, Chiu, April, Tam, Wayne, Knowles, Daniel M., Dillon, Stacey R., Leonard, John P., Furman, Richard R., Chen, Kang, Cerutti, Andrea
Publicado em 2012

Ibrutinib Resistance in Chronic Lymphocytic Leukemia

Por Furman, Richard R., Cheng, Shuhua, Lu, Pin, Setty, Menu, Perez, Alexendar R., Guo, Ailin, Racchumi, Joelle, Xu, Guozhou, Wu, Hao, Ma, Jiao, Steggerda, Susanne M., Coleman, Morton, Leslie, Christina, Wang, Y. Lynn
Publicado no N Engl J Med (2014)

SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response

Por Bologna, Cinzia, Buonincontri, Roberta, Serra, Sara, Vaisitti, Tiziana, Audrito, Valentina, Brusa, Davide, Pagnani, Andrea, Coscia, Marta, D’Arena, Giovanni, Mereu, Elisabetta, Piva, Roberto, Furman, Richard R., Rossi, Davide, Gaidano, Gianluca, Terhorst, Cox, Deaglio, Silvia
Publicado no J Clin Invest (2015)

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

Por de Vos, Sven, Forero-Torres, Andres, Ansell, Stephen M, Kahl, Brad, Cheson, Bruce D, Bartlett, Nancy L, Furman, Richard R, Winter, Jane N, Kaplan, Henry, Timmerman, John, Whiting, Nancy C, Drachman, Jonathan G, Advani, Ranjana
Publicado em 2014

A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)

Por Kahl, Brad S., Spurgeon, Stephen E., Furman, Richard R., Flinn, Ian W., Coutre, Steven E., Brown, Jennifer R., Benson, Don M., Byrd, John C., Peterman, Sissy, Cho, Yoonjin, Yu, Albert, Godfrey, Wayne R., Wagner-Johnston, Nina D.
Publicado no Blood (2014)

A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254

Por Furman, Richard R., Grossbard, Michael L., Johnson, Jeffrey L., Pecora, Andrew L., Cassileth, Peter A., Jung, Sin-Ho, Peterson, Bruce A., Nadler, Lee M., Freedman, Arnold, Bayer, Ruthee-Lu, Bartlett, Nancy L., Hurd, David D., Cheson, Bruce D.
Publicado em 2011

Phase 1 study of radio sensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with (131)I-tositumomab

Por Elstrom, Rebecca L., Ruan, Jia, Christos, Paul J., Martin, Peter, Lebovic, Daniel, Osborne, Joseph, Goldsmith, Stanley, Greenberg, June, Furman, Richard R., Avram, Anca, Putman, Ryan, Chapman, Erica, Mazumdar, Madhu, Griffith, Kent, Coleman, Morton, Leonard, John P., Kaminski, Mark S.
Publicado no Leuk Lymphoma (2014)

Management of adverse events associated with idelalisib treatment: expert panel opinion

Por Coutré, Steven E., Barrientos, Jacqueline C., Brown, Jennifer R., de Vos, Sven, Furman, Richard R., Keating, Michael J., Li, Daniel, O’Brien, Susan M., Pagel, John M., Poleski, Martin H., Sharman, Jeff P., Yao, Nai-Shun, Zelenetz, Andrew D.
Publicado no Leuk Lymphoma (2015)

A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia

Por Byrd, John C., Pagel, John M., Awan, Farrukh T., Forero, Andres, Flinn, Ian W., Deauna-Limayo, Delva P., Spurgeon, Stephen E., Andritsos, Leslie A., Gopal, Ajay K., Leonard, John P., Eisenfeld, Amy J., Bannink, Jeannette E., Stromatt, Scott C., Furman, Richard R.
Publicado em 2014

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma

Por Mark, Tomer, Jayabalan, David, Coleman, Morton, Pearse, Roger N., Wang, Y. Lynn, Lent, Richard, Christos, Paul J., Lee, Joong W., Agrawal, Yashpal P., Matthew, Susan, Ely, Scott, Mazumdar, Madhu, Cesarman, Ethel, Leonard, John P., Furman, Richard R., Chen-Kiang, Selina, Niesvizky, Ruben
Publicado em 2008